Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer

Bibliografische gegevens
Hoofdauteurs:	Gillies, R, Delaney, D, Warren, B, Sharma, R, Middleton, MR
Formaat:	Conference item
Gepubliceerd in:	2011

Gelijkaardige items

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer
door: Gillies, R, et al.
Gepubliceerd in: (2012)

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer.
door: Gillies, R, et al.
Gepubliceerd in: (2012)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
door: Hatch, S, et al.
Gepubliceerd in: (2014)

Role of endonucleases XPF and XPG in nucleotide excision repair of platinated DNA and cisplatin/oxaliplatin cytotoxicity
door: Graf, Nora, et al.
Gepubliceerd in: (2012)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
door: MacGregor, T, et al.
Gepubliceerd in: (2018)

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection
door: Hatch, S, et al.
Gepubliceerd in: (2014)

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma
door: T. P. MacGregor, et al.
Gepubliceerd in: (2018-05-01)

Use of DNA repair proteins translated from biomarker screening to predict overall survival in patients with esophageal cancer treated with oxaliplatin chemotherapy
door: Sharma, R, et al.
Gepubliceerd in: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
door: Gillies, R, et al.
Gepubliceerd in: (2012)

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma
door: Gillies, R, et al.
Gepubliceerd in: (2012)

XPF-ERCC1: Linchpin of DNA crosslink repair
door: McHugh, PJ
Gepubliceerd in: (2020)

XPF-ERCC1: Linchpin of DNA crosslink repair.
door: Peter J McHugh
Gepubliceerd in: (2020-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
door: Mariangela Sabatella, et al.
Gepubliceerd in: (2021-01-01)

Challenges in assessing response of oesophageal cancer to neoadjuvant therapy, and the potential of composite PET-CT and multimodal metrics.
door: Findlay, J, et al.
Gepubliceerd in: (2017)

Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy.
door: Yang, J, et al.
Gepubliceerd in: (2010)

Oesophageal and gastro-oesophageal junction tumours
door: Bird-Lieberman, E, et al.
Gepubliceerd in: (2007)

Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
door: Anwaar Ahmad, et al.
Gepubliceerd in: (2010-03-01)

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.
door: Findlay, J, et al.
Gepubliceerd in: (2017)

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer
door: den Boer, RB, et al.
Gepubliceerd in: (2020)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
door: Ming-Yii Huang, et al.
Gepubliceerd in: (2023-05-01)

Biochemical studies on the role of the XPF-ERCC1 endonuclease in repairing damaged DNA replication forks
door: Abdullah, U
Gepubliceerd in: (2015)

ERCC1/XPF Is Important for Repair of DNA Double-Strand Breaks Containing Secondary Structures
door: Shibo Li, et al.
Gepubliceerd in: (2019-06-01)

Neoadjuvant chemotherapy for oesophageal carcinoma - a risk factor for postoperative pneumonia?
door: Millo, J, et al.
Gepubliceerd in: (2003)

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression
door: Kaina Bernd, et al.
Gepubliceerd in: (2010-09-01)

Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors
door: Thomas, A, et al.
Gepubliceerd in: (2019)

Oesophageal carcinoma: The prevalence of DNA tumour viruses and therapy
door: Sile Li, et al.
Gepubliceerd in: (2022-06-01)

XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair.
door: Bhagwat, N, et al.
Gepubliceerd in: (2009)

Function and Interactions of ERCC1-XPF in DNA Damage Response
door: Maryam Faridounnia, et al.
Gepubliceerd in: (2018-12-01)

Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation
door: Jiajia Wang, et al.
Gepubliceerd in: (2020-02-01)

Human SNM1a and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair
door: Wang, A, et al.
Gepubliceerd in: (2011)

Human SNM1A and XPF-ERCC1 collaborate to initiate DNA interstrand cross-link repair.
door: Wang, A, et al.
Gepubliceerd in: (2011)

Propensity score regression analysis of oesophageal adenocarcinoma treatment with surgery alone or neoadjuvant chemotherapy
door: A. G. M. T. Powell, et al.
Gepubliceerd in: (2020-08-01)

Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapy
door: Findlay, J, et al.
Gepubliceerd in: (2016)

Effect of neoadjuvant chemotherapy on the immune microenvironment of gynaecological tumours
door: Jing Xue, et al.
Gepubliceerd in: (2023-12-01)

Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
door: Xin Zhang, et al.
Gepubliceerd in: (2021-07-01)

Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
door: Gillies, R, et al.
Gepubliceerd in: (2011)

Survival after curative chemoradiotherapy or neoadjuvant therapy and surgery converges in higher-risk patients with oesophageal cancer
door: Rana, M, et al.
Gepubliceerd in: (2021)

A “Inscrição do Harém” de Xerxes (XPf): introdução crítica, tradução de XPf/OP para o português, comparação com XPf/AB e comentários
door: Matheus Treuk Medeiros de Araújo
Gepubliceerd in: (2024-05-01)

NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinoma
door: Mukherjee, S, et al.
Gepubliceerd in: (2017)

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer
door: Gillies, R, et al.
Gepubliceerd in: (2010)